WORLD BUSINESS BRIEFING: EUROPE; ANTIBIOTICS LIFT BAYER

Third-quarter net income from continuing operations at Bayer A.G.rose 24 percent, to 534 million euros ($459 million), or 0.74 euro a share, helped by rising sales of the antibiotic Ciprobay and other drugs. Higher raw material prices held back gains in the chemicals and polymers businesses, the company said.